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Background: Wound healing trajectories (percent healing vs time) provide a dynamic
pictureofthedecreaseinwoundburdenovertheentirecontinuumofthehealingprocess.
Trajectories can be robustly compared using survival statistics methodology. Improve-
ment in healing can be determined by shifting the curve from “impaired” healing toward
“ideal”healing.Althoughthisconceptofshiftingthecurve“totheleft”hasbeendemon-
strated in acute incisional healing depicted by the gain in tensile strength, and in other
chronic wounds, it has not been utilized for chronic pressure ulcers. Methods: Wound
healing trajectories were constructed for 211 patients enrolled in 8 separate random-
ized clinical trials for grade III and IV pressure ulcers. Trajectories were constructed
for patients achieving ≥90% or more healing within 112 days and those who achieved
less than <90% wound closure. Kaplan-Meier curves were constructed for all patients
receiving an experimental treatment and for those receiving placebo vehicles. Results:
Different trajectories were achieved for the faster healing patients. Eighty-one percent
of patients reached 90% healing within 112 days; 80% of those in treatment groups and
85% of those in placebo groups. Linear regression suggested that all patients entered
into the clinical trials would achieve 90% healing by 18 weeks. Only 17% of the pa-
tients achieved total healing (100% wound closure) within the 112-day study period.
Linear regression suggested that it would take 110 weeks to achieve total healing in all
patients. Conclusion: Wound healing trajectories provide a more complete description
of treatment efﬁcacy than do ﬁxed endpoints, such as the number of patients achieving
100% closure at one deﬁned time point. Since more successful healers have different
trajectoriesthanlesssuccessfulhealers,shiftingthetrajectorytotheleftfrom“impaired”
toward “ideal” healing may provide a better endpoint to determine treatment efﬁcacy.
Wound repair processes depend on the interaction of many time-dependent components.1
A wound healing trajectory allows one to evaluate the outcome of healing versus time.
Knowingtimeforhealingisvital,asincreasedtimecorrelateswithgreaterratesofinfection
and scarring. The wound healing trajectory integrates the many time-dependent processes
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that are part of the healing process and is affected by systemic and local deterrents to
healing. These trajectories clearly display increased healing (reﬂected by a left shift of
the curve) or “impaired” healing (reﬂected by a right shift of the curve). Actual wound
healing is different from “ideal” wound healing due to deterrents to healing, which shift
the trajectory to the right toward “impaired” healing. The goal for an agent attempting to
accelerate the healing process is to shift the curve to the left, toward the “ideal.”1
Becausehealingofopenwoundsfollowsanexponentialcurve,woundhealingtrajecto-
ries (percent wound closure vs time) have been used to describe chronic wound healing.1−3
Although wound healing trajectories were initially described for acute wounds, they can
also be used to evaluate the healing of chronic wounds, such as diabetic ulcers, pressure
ulcers, and venous stasis ulcers. The trajectory curve, similar to the Gompertz growth
curve for biological systems, is sigmoid-shaped, with time on the x-axis and percentage of
wound closure on the y-axis.4−6,7 This exponential healing process is based on the equation
expressed by DuNouy,8 with the rate of change of wound area decreasing as the residual
wound area approaches total closure.
Trajectories allow examination of the entire continuity of wound healing, at any time
pointratherthanatseveraldistinctpoints.Althoughanumberofmodelshavebeenproposed
to describe wound healing (both linear and nonlinear), we have utilized the wound healing
trajectory approach proposed by Hokanson et al,9 which leaves the raw data for wound area
free of mathematical transformation.4,8 Using this mathematical model, we have been able
toapproximatetheactualwoundclosuremeasurementsandutilizeendpointanalysissimilar
to that used in failure-time studies. This analytical strategy has been applied successfully to
large groups of experimental wound healing studies.4 In this method of analysis, a wound
healing trajectory is created on the basis of a plot of percentage of wound closure versus
time of wound treatment and can then be used to predict healing and determine the efﬁcacy
of a therapeutic agent.
With this wound healing trajectory plot, the time required to achieve a certain percent-
age of healing can be measured, using survival study methods as described by Kaplan and
Meier.9,10,15 Utilizing statisticalanalysis methods used for failure-time or survival analysis,
the distributions of fractional closure times can be examined for statistical differences.11
The usefulness of wound healing trajectories as predictors of efﬁcacy of therapeutic agents
for diabetic foot ulcers and venous stasis ulcers has been previously demonstrated and




Wound healing trajectories were constructed from 211 patients enrolled in 8 randomized
clinical trials for grade III and IV pressure ulcers.6 All studies were approved by insti-
tutional review board for human studies. Patients were treated between 28 and 112 days,
depending on the speciﬁc protocol. The inclusion/exclusion criteria, standards of care, and
care providers were similar for all patients. Pressure ulcer size was quantiﬁed utilizing jel-
trate molds; serial molds were used to describe healing trajectories during the course of the
treatment protocols. Healing fractions (mold size on day X/mold size on day 0) were used
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Figure 1. Curves depicting mean and median values for healing fraction over 112 days. Squares
indicate patients who achieved ≥90% wound closure; circles indicate patients who achieved less
than <90% wound closure. Healing fraction refers to percentage of initial wound, calculated as
wound mold size on day X/wound mold size on day 0.
to describe the course of healing over time. Healing fractions provided the data for both
the healing trajectories and Kaplan-Meier survival analyses. Trajectories were constructed
for patients achieving ≥90% (faster) and < 90% (slower) healing within 112 days. Kaplan-
Meier curves were constructed for all patients receiving an experimental treatment and for
those receiving placebo vehicles.
STATISTICAL METHODOLOGY
Survival analyses were performed with the Kaplan-Meier method, using log-rank and
Wilcoxon statistics to test between groups. Calculations and graphs were constructed uti-
lizing SigmaStat and SigmaPlot software (SPSS, Chicago, Ill), and also JMP software
(SAS, Carey, NC).
RESULTS
Figure 1 depicts the markedly different trajectories for patients in the faster versus slower
healing groups. Survival analysis suggests that 81% percent of all patients reached 90%
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healingwithin112days.Alinearregression(Fig2)ofthesedataindicatesthatallpatientsin
these clinical trials would achieve 90% healing by 18 weeks. Survival analysis by treatment
groups (Fig 3) suggests that 80% of those in all treatment groups combined and 85%
of those in all placebo groups combined achieved 90% healing within 112 days; these
differences were not signiﬁcant (Wilcoxon, P = .43; and log rank test, P = .41). Signiﬁcant
differences were seen among treatment and placebo groups within individual studies (data
not shown). Only 17% of the patients achieved total healing (100% wound closure) within
the study period of 112 days (Fig 4). Linear regression of survival analysis data suggested
that it would take almost 110 weeks to achieve total healing in all patients.
Figure 2. Kaplan-Meier healing curve depicting the percentage of patients achieving 90% wound
closure. Linear regression indicates that all patients would achieve 90% healing by 18 weeks.
DISCUSSION
The goal of most clinical wound healing research is to discover and/or study products and
processesthatmightacceleratewoundhealing.12 Onelimitingfactorinclinicaltrialstesting
therapeutic agents has been trial design, including the methodology and determination of
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Figure 3. Kaplan-Meier healing curves depicting percentage of patients achieving 90% wound
closure, by treatment. Eighty percent of those in all treatment groups combined and 85% of those
in all placebo groups combined achieved 90% healing within 112 days; these differences were not
signiﬁcant (Wilcoxon, P = .43; and log rank test, P = .41). Signiﬁcant differences were seen among
treatment and placebo groups within individual studies (data not shown).
endpoints.4 To evaluate treatment efﬁcacy, outcome measures or clinical endpoints are
necessary, and a number of studies have suggested various outcome measures for the
healing of open chronic wounds.4 According to the US Food and Drug Administration, the
only acceptable treatment outcome for wounds is total wound healing (100% closure).13
In the study trials, only 17% of patients achieved total healing within the allotted study
period, 112 days (Fig 4). The data suggest that all patients receiving the proper level of
wound care will achieve 100% wound closure by 110 weeks. Therefore, a clinical trial
would have to last at least 110 weeks, an impractical and expensive endeavor, to allow
for the best determination of this efﬁcacy endpoint (100% closure). Clearly, the time to
100%healinginallpatientsplacesunreasonabletimeconstraintsonpatientparticipationin
treatment protocols. The tremendous costs of such a large clinical trial point to a great need
for intermediate endpoints that can serve as efﬁcacy endpoints, hence a focus on wound
healing trajectories.
The wound healing trajectory has been shown to be a valid and useful representation
of the exponential course of the healing of wounds, with the rate of change of wound area
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Figure 4. Kaplan-Meier healing curve depicting percentage of patients achieving 100% wound
closure. Seventeen percent of patients achieved total healing within 112 days. Linear regression of
survival analysis data suggests that it would take almost 110 weeks to achieve total healing in all
patients.
progressively decreasing as the residual wound area approaches total closure.4,14 Wound
healingtrajectoriesdescribethe entirecontinuumof thewound healingprocess,asopposed
to statistical analyses like the t test that are performed on a single point.8 These trajectories
provide better insight into treatment efﬁcacy than do ﬁxed endpoints, that is, the number of
patients achieving 100% closure at one predeﬁned time point.15 With these trajectories, the
time required to reach a certain percentageof healingcan be calculated.These distributions
of times to an event (90% wound closure) can then undergo standard statistical failure-time
analysis and can be just as rigorous as total (100%) ulcer healing statistics.
Trajectories can be utilized for both acute and chronic wounds alike, but in this study,
we have focused on chronic wounds and speciﬁcally examined the healing trajectories of
pressure ulcers. Although partial healing is not recognized as an acceptable wound healing
endpoint by the Food and Drug Administration, the use of wound healing trajectories to
determine time to a certain level of partial healing can be considered an efﬁcacy outcome
measure as previously described.4,5,11 Venous stasis ulcers and diabetic foot ulcers show
trajectory outcomes from independent clinical trials that closely mimic each other. In
addition, the trajectories of patients achieving 100% closure in a certain time period were
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very different from the trajectories of patients not achieving total healing in that same time
period.
The results of this current study show that more successful healers have different
trajectories than less successful healers. Therefore, a shift of the trajectory to the left from
“impaired” toward “ideal” healing may provide a better endpoint to determine treatment
efﬁcacy.1 The concept of a trajectory shift of patients with less than 100% closure in
a deﬁned period to the trajectory of patients attaining total ulcer closure could be used
to determine new therapeutic agent efﬁcacy. Our goal in this study was to point out the
predictive value of wound healing trajectories for pressure ulcers. Ideally, shorter clinical
trials can be constructed relying on speciﬁc shifts of the wound healing trajectories from
impaired healing toward an ideal endpoint.4,5
CONCLUSION
Wound healing trajectories appear to be a useful tool for evaluation of time to healing,
especiallywiththeutilizationofclinicaldata.Woundhealingtrajectorieshavebeenshownto
beofutilityintheevaluationofacutewoundsandofchronicwoundsincludingvenousstasis
ulcers and diabetic foot ulcers. This current study validates wound trajectory utilization for
pressure ulcers. Using wound healing trajectories may allow for more efﬁcient clinical trial
protocol design in future wound healing trials.
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